Draft Guidance for Industry: Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption
2018-10-22
FDA-2018-D-3631
指导原则
美国
现行有效
/
美国食品药品监督管理局(FDA)
GUIDANCE DOCUMENT
Draft Guidance for Industry: Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption October 2018
Not for implementation. Contains non-binding recommendations.
The purpose of this draft compliance and implementation guidance document is to help covered farms comply with the requirements of the Produce Safety Rule, which establishes science-based minimum standards for the safe growing, harvesting, packing, and holding of produce. Entitled “Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption,” the rule is part of FDA’s implementation of the FDA Food Safety Modernization Act (FSMA).
The draft guidance provides a broad range of recommendations on how to meet the requirements for most subparts of the rule. It also outlines how to determine whether produce or farms may be eligible for exemptions from certain requirements, or from the rule in its entirety.
Specific regulatory or statutory requirements are cited, and in some cases, specified using the word must. The use of the word should indicates that something is recommended, but not required. The use of the word including means options that are not limited to the described items.
You are encouraged to submit comments on the draft guidance within 180 days of the publish date to ensure your comments are considered while FDA works on the final version of the guidance.
In addition to the draft guidance, there is an At-a-Glance overview of key points in each of the nine chapters described below, as well as a glossary of key terms. The overviews summarize important aspects of each chapter. It is recommended that you review the draft guidance itself for complete information.
This chapter will help you determine if your farm and your produce are subject to the requirements in the Produce Safety Rule. The topics in this chapter will help you understand:
- Who is subject to the Produce Safety Rule?
- What is “covered produce”?
- What is a “covered farm”?
- What is a “covered activity”?
- What produce is either not covered or eligible for an exemption?
Draft Guidance Chapter 1: General Provisions (Subpart A) (PDF: 1.7MB)
Additional Information:
- At a Glance: Key Points in Chapter 1 (PDF: 98.7KB); Descripción General: Capitulo 1 (PDF: 145KB)
- Key Terms Glossary (PDF: 130KB)
- Coverage/Exclusions Flowchart (PDF: 54.4KB); Cobertura y exenciones (PDF: 63KB)
- FSMA Inflation Adjusted Cut Offs
This chapter will help you evaluate personnel qualifications (such as education, training and experience) and comply with training requirements in the Produce Safety Rule. Topics covered by this chapter include:
- Who is required to have a combination of training, education, or other experience necessary to perform their duties that ensures compliance with the rule?
- How often must personnel receive training?
- What topics are the focus of training?
- Who can provide training?
- How should training be conducted?
Draft Guidance Chapter 2: Personnel Qualifications and Training (Subpart C) (PDF: 1.7MB)
Additional Information:
- At a Glance: Key Points in Chapter 2 (PDF: 94.6KB); Descripción General: Capitulo 2 (PDF: 92KB)
- Key Terms Glossary (PDF: 130KB)
- Produce Safety Alliance
- Produce International Partnership for Outreach and Education
This chapter provides recommendations on how to use hygienic practices to prevent the contamination of produce and food contact surfaces. Topics covered by this chapter include:
- Health and hygiene considerations for farm personnel, supervisors, and visitors
- The types of health conditions that concern FDA
- The requirements for personnel who report or demonstrate “applicable health conditions”
- Actions to take if you suspect produce or food contact surfaces may have been contaminated
- Recommendations related to hygienic practices
Draft Guidance Chapter 3: Health and Hygiene (Subpart D) (PDF: 1.7MB)
Additional Information:
- At a Glance: Key Points in Chapter 3 (PDF: 83.9KB); Descripción General: Capitulo 3 (PDF: 78KB)
- Key Term Glossary (PDF: 130KB)
This chapter will help you implement required practices for reducing the risk of produce contamination from certain soil amendments that consist of materials of animal origin, such as manure or non-fecal animal byproducts, which are added to soil to help plant growth or to improve the capacity of the soil to retain water. Topics covered by this chapter include:
- What is a biological soil amendment of animal origin (BSAAO)?
- The difference between “treated” and “untreated” BSAAOs
- Treatment processes
- Application of BSAAOs
- Recommendations for handling, transporting, and storing BSAAOs
- Records requirements and recommendations
Draft Guidance Chapter 4: Biological Soil Amendments of Animal Origin (Subpart F) (PDF: 1.7MB)
Additional Information:
- At a Glance: Key Points in Chapter 4 (PDF: 86.6KB); Descripción General: Capitulo 4 (PDF: 68KB)
- Key Terms Glossary (PDF: 130KB)
This chapter will help you determine whether Subpart I applies to you, and if so, what needs to be done to assess relevant areas on your farm for potential contamination and to evaluate significant evidence of potential contamination. Topics covered in this chapter include:
- How to determine whether, under the circumstances, there is a reasonable probability that domesticated and wild animals will contaminate your covered produce
- How to assess your relevant outdoor areas and partially-enclosed buildings for potential animal contamination
- How to perform monitoring activities
- How to determine if potential contamination is significant
Draft Guidance Chapter 5: Domesticated and Wild Animals (Subpart I) (PDF: 1.7MB)
Additional Information:
- At a Glance: Key Points in Chapter 5 (PDF: 86.6KB); Descripción General: Capitulo 5 (PDF: 78KB)
- Key Terms Glossary (PDF: 130KB)
This chapter provides recommendations on practices for safe growing, harvesting packing, and holding activities on your farm. Topics covered in this chapter include:
- What to do if you grow both covered and not covered, or excluded, produce
- Identifying and not harvesting potentially contaminated produce
- Recommendations for the safe handling of harvested produce
- Considerations for the safe packaging of produce
- Recommendations for food-packing materials
Draft Guidance Chapter 6: Growing, Harvesting, Packing, and Holding Activities (Subpart K) (PDF: 1.7MB)
Additional Information:
- At a Glance: Key Points in Chapter 6 (PDF: 87.1KB); Descripción General: Capitulo 6 (PDF: 78KB)
- Key Terms Glossary (PDF: 130KB)
This chapter provides recommendations for practices related to equipment, tools, buildings, and sanitation. Topics covered in this chapter include:
- Recommendations for equipment and tools, including design, construction and workmanship; storage; maintenance; cleaning, and when necessary and appropriate sanitizing; and inspection
- Considerations for instruments and controls used to measure, regulate or record conditions to control or prevent the growth of microorganisms
- Recommendations for buildings, including size, construction and design
- How to perform pest control activities
- Recommendations for toilet and hand-washing facilities
- Considerations for sewage systems, including use and maintenance and response to leaks and significant events;
- Recommendations for trash, litter and waste, including collection, storage and disposal
- Considerations for plumbing
- Records recommendations and requirements
Draft Guidance Chapter 7: Equipment, Tools, Buildings, and Sanitation (subpart L) (PDF: 1.7MB)
Additional Information:
- At a Glance: Key Points in Chapter 7 (PDF: 119KB); Descripción General: Capitulo 7 (PDF: 113KB)
- Key Terms Glossary (PDF: 130KB)
This chapter will help you better understand how to create and maintain records required under the Produce Safety Rule. Topics covered by this chapter include:
- How to incorporate information that all records must include
- Recommendations for storing and retaining records
- Options for records format
Draft Guidance Chapter 8: Records (Subpart O) (PDF: 1.7MB)
Additional Information:
- At a Glance: Key Points in Chapter 8 (PDF: 90.3KB); Descripción General: Capitulo 8 (PDF: 61KB)
- Chapter 8: Records Chart (PDF: 70.2KB); Descripción General: Cuadro de Registros (PDF: 54.1KB)
- Key Terms Glossary (PDF: 130KB)
This chapter will help you better understand how variances can be used and how to prepare a variance request. Topics covered in this chapter include:
- Who can submit a variance petition?
- What a variance petition must include and demonstrate
- Recommended information to include in a variance request
- The process for requesting a variance
Draft Guidance Chapter 9: Variances (Subpart P) (PDF: 1.7MB)
Additional Information:
- At a Glance: Key Points in Chapter 9 (PDF: 68.6KB); Descripción General: Capitulo 9 (PDF: 52KB)
Related Information
- Download the Full Draft Guidance(PDF: 1.7MB)
- Download all PDF At-a-Glance Overviews of the Produce Safety Rule Draft Guidance chapters (ZIP: 824KB)
- Final Produce Safety Rule
- This page includes links to the rule in the Federal Register. In addition to detailing the requirements, the Federal Register posting provides access to the preamble to the rule, which captures FDA’s response to concerns and questions raised in the public comment period.
- This page also has supporting material that includes fact sheets, related draft guidances and communications from FDA leadership.
- Produce Safety Rule in the Code of Federal Regulations
- You can also read the rule provisions in the CFR, which contains federal rules and regulations.
- Temporary Policy During the COVID-19 Public Health Emergency Regarding the Qualified Exemption from the Standards for the Growing, Harvesting, Packing, and Holding of Produce for Human Consumption
Submit Comments
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2018-D-3631.
最新政策法规资讯
-
摩熵医药2026-06-17
-
摩熵医药2026-06-09
-
赛柏蓝2026-06-01
-
深蓝观2026-05-22
-
赛柏蓝2026-04-24
-
摩熵医械2026-01-28
-
摩熵医械2026-01-13
-
摩熵医械2025-12-19
-
赛柏蓝2025-12-12
-
摩熵医械2025-11-28
热门政策标签
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
-
2026-10-14
-
2026-10-14
-
摩熵咨询 35 78
-
摩熵咨询 28 65
-
颁布机构:国家市场监督管理总局 2026-09-30
-
颁布机构:国家市场监督管理总局 2026-09-29
最新指导原则
-
国家药监局器审中心关于发布<人表皮生长因子受体2基因扩增检测试剂(荧光原位杂交法)注册审查指导原则(2026年修订版)>等2项注册审查指导原则的通告(2026年第28号)
2026-10-13
-
questions and answers on biosimilar development and the bpci act: guidance for industry(生物类似药开发与<生物制品价格竞争与创新法案>问答:行业指南)
2026-10-09
-
postapproval manufacturing changes to biosimilar and interchangeable biosimilar products: questions and answers(生物类似药和可互换生物类似药产品的批准后生产变更:问答)
2026-10-09
-
国家药监局器审中心关于发布有源植入式医疗器械电池注册审查指导原则的通告(2026年第27号)
2026-10-08
-
国家药监局器审中心关于发布腹腔内窥镜手术系统注册审查指导原则 第5部分:患者模型试验研究>的通告(2026年第26号)
2026-09-28
-
国家药监局综合司公开征求<医疗器械生产质量管理规范无菌医疗器械检查指导原则(征求意见稿)>等意见
2026-09-24
-
关于公开征求ich<e14/s7b:问答:致qt/qtc 间期延长及潜在致心律失常作用的临床和非临床评价问答>指导原则问答文件实施建议和中文翻译稿意见的通知
2026-09-24
-
国家药监局药审中心关于发布<药物临床试验计算机化系统和电子数据指导原则>的通告
2026-09-22
-
国家药监局药审中心关于发布<化学仿制药滴眼剂研究技术指导原则>和<化学仿制药特殊滴眼剂研究技术指导原则>的通告
2026-09-02
-
determining whether to submit an anda or a 505(b)(2) application(确定是提交仿制药申请(anda)还是505(b)(2)申请)
2026-08-17
-
cvm gfi #260 - type vii veterinary master file for research and development and risk reviews(cvm行业指南第260号——用于研发与风险审查的vii型兽药主文件)
2026-08-14
-
container closure systems for human drugs and biological products(人用药品和生物制品的容器密闭系统)
2026-08-13
-
formal meetings between the fda and sponsors or applicants of pdufa products(关于fda与处方药使用者付费法案(pdufa)产品申办方或申请人之间正式会议的指南)
2026-08-12
-
国家卫生健康委办公厅关于印发医疗机构卒中中心建设与管理指导原则(2026年版)的通知
2026-07-28
-
hemodialysis blood tubing sets - premarket notification (510(k)) submissions: guidance for industry and food and drug administration staff(血液透析血液管路套装 - 上市前通知(510(k))申报资料:行业和食品药品监督管理局工作人员指南)
2026-07-23
全球药物研发中心
全球研发数据与行业前沿情报
-
2026-10-15
-
2026-10-15
-
2026-10-15
-
摩熵咨询 33 34
-
摩熵咨询 20 8
-
摩熵咨询 20 12
-
颁布机构:国家药品监督管理局药品审评中心 2026-09-28
-
颁布机构:国家药品监督管理局 2026-09-10
-
颁布机构:四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
同部门最新指导原则
-
Nonclinical Safety Assessment of Oligonucleotide-Based Therapeutics
2024-11-15
-
Guidance for Industry: FDA's Voluntary Qualified Importer Program
2024-11-14
-
CPG Sec 540.525 Scombrotoxin (Histamine)-forming Fish and Fishery Products – Decomposition and Histamine (CPG 7108.24)
2024-11-01
-
Study Data Technical Conformance Guide - Technical Specifications Document
2024-10-31
-
M13A Bioequivalence for Immediate-Release Solid Oral Dosage Forms
2024-10-30
-
CVM GFI #293 - FDA Enforcement Policy for AAFCO-Defined Animal Feed Ingredients
2024-10-24
-
Guidance for Industry: Insanitary Conditions in the Preparation, Packing, and Holding of Tattoo Inks and the Risk of Microbial Contamination
2024-10-22
-
Drug Interaction Information in Human Prescription Drug and Biological Product Labeling
2024-10-21
-
Review of Drug Master Files in Advance of Certain ANDA Submissions Under GDUFA
2024-10-17
-
Postoperative Nausea and Vomiting: Developing Drugs for Prevention
2024-10-17
-
Recommendations for the Development of Blood Collection, Processing, and Storage Systems for the Manufacture of Blood Components Using the Buffy Coat Method
2024-10-17
-
Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development: Guidance for Industry
2024-10-17
-
Core Patient-Reported Outcomes in Cancer Clinical Trials: Guidance for Industry
2024-10-17
-
Requests for Reconsideration at the Division Level Under GDUFA
2024-10-16
-
CVM GFI #284 Using Relative Supersaturation to Support “Urinary Tract Health” Claims for Adult Maintenance Cat Food
2024-10-15
同地域最新指导原则
-
questions and answers on biosimilar development and the bpci act: guidance for industry(生物类似药开发与<生物制品价格竞争与创新法案>问答:行业指南)
2026-10-09
-
postapproval manufacturing changes to biosimilar and interchangeable biosimilar products: questions and answers(生物类似药和可互换生物类似药产品的批准后生产变更:问答)
2026-10-09
-
determining whether to submit an anda or a 505(b)(2) application(确定是提交仿制药申请(anda)还是505(b)(2)申请)
2026-08-17
-
cvm gfi #260 - type vii veterinary master file for research and development and risk reviews(cvm行业指南第260号——用于研发与风险审查的vii型兽药主文件)
2026-08-14
-
container closure systems for human drugs and biological products(人用药品和生物制品的容器密闭系统)
2026-08-13
-
formal meetings between the fda and sponsors or applicants of pdufa products(关于fda与处方药使用者付费法案(pdufa)产品申办方或申请人之间正式会议的指南)
2026-08-12
-
hemodialysis blood tubing sets - premarket notification (510(k)) submissions: guidance for industry and food and drug administration staff(血液透析血液管路套装 - 上市前通知(510(k))申报资料:行业和食品药品监督管理局工作人员指南)
2026-07-23
-
opioid analgesic drugs: considerations for benefit-risk assessment framework(阿片类镇痛药:效益-风险评估框架的考量)
2026-05-13
-
development of non-opioid analgesics for acute pain(急性疼痛的非阿片类镇痛药开发)
2026-05-13
-
development of local anesthetic drug products with prolonged duration of effect(延长作用时间的局部麻醉药品的开发)
2026-05-13
-
stimulant use disorders: developing drugs for treatment(兴奋剂使用障碍:治疗药物的开发)
2026-05-13
-
development of non-opioid analgesics for chronic pain(慢性疼痛非阿片类镇痛药的开发)
2026-05-13
-
pulmonary tuberculosis: developing drugs for treatment(肺结核:治疗药物的开发)
2026-05-08
-
clostridioides difficile infection: developing drugs for treatment, reduction of recurrence, and prevention(艰难梭菌感染:用于治疗、减少复发及预防的药物开发)
2026-05-08
-
enforcement priorities for certain new tobacco products marketed without premarket authorization(未经上市前授权销售的某些新烟草产品的执法重点)
2026-05-08

